A gene therapy medical product is defined by the European Medicines Agency (EMA) as having two characteristics: (a) it comprises an active substance that contains or consists of a recombinant nucleic acid utilized in or provided to human beings with a view to regulating, correcting, replacing, or adding or deleting a genetic sequence; and (b) its therapeutic, prophylactic, or diagnostic impact relates directly to the recombinant nucleic acid. Vaccines against infectious illnesses are not permitted in gene therapy ,however clinical successes in 2009-2011 have bolstered new optimism in the promise of gene therapy. These include successful treatment of patients with the retinal disease Leber congenital amaurosis X‑linked SCID, ADA–SCID, adrenoleukodystrophy, and Parkinson’s disease,
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : Books Puddle, Woodside, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26395835597
Quantité disponible : 4 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand. N° de réf. du vendeur 400574226
Quantité disponible : 4 disponible(s)
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -A gene therapy medical product is defined by the European Medicines Agency (EMA) as having two characteristics: (a) it comprises an active substance that contains or consists of a recombinant nucleic acid utilized in or provided to human beings with a view to regulating, correcting, replacing, or adding or deleting a genetic sequence; and (b) its therapeutic, prophylactic, or diagnostic impact relates directly to the recombinant nucleic acid. Vaccines against infectious illnesses are not permitted in gene therapy ,however clinical successes in 2009-2011 have bolstered new optimism in the promise of gene therapy. These include successful treatment of patients with the retinal disease Leber congenital amaurosis X linked SCID, ADA-SCID, adrenoleukodystrophy, and Parkinson's disease, 84 pp. Englisch. N° de réf. du vendeur 9786204985480
Quantité disponible : 2 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. PRINT ON DEMAND. N° de réf. du vendeur 18395835591
Quantité disponible : 4 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A gene therapy medical product is defined by the European Medicines Agency (EMA) as having two characteristics: (a) it comprises an active substance that contains or consists of a recombinant nucleic acid utilized in or provided to human beings with a view . N° de réf. du vendeur 689748048
Quantité disponible : Plus de 20 disponibles
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - A gene therapy medical product is defined by the European Medicines Agency (EMA) as having two characteristics: (a) it comprises an active substance that contains or consists of a recombinant nucleic acid utilized in or provided to human beings with a view to regulating, correcting, replacing, or adding or deleting a genetic sequence; and (b) its therapeutic, prophylactic, or diagnostic impact relates directly to the recombinant nucleic acid. Vaccines against infectious illnesses are not permitted in gene therapy ,however clinical successes in 2009-2011 have bolstered new optimism in the promise of gene therapy. These include successful treatment of patients with the retinal disease Leber congenital amaurosis X linked SCID, ADA-SCID, adrenoleukodystrophy, and Parkinson's disease, N° de réf. du vendeur 9786204985480
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -A gene therapy medical product is defined by the European Medicines Agency (EMA) as having two characteristics: (a) it comprises an active substance that contains or consists of a recombinant nucleic acid utilized in or provided to human beings with a view to regulating, correcting, replacing, or adding or deleting a genetic sequence; and (b) its therapeutic, prophylactic, or diagnostic impact relates directly to the recombinant nucleic acid. Vaccines against infectious illnesses are not permitted in gene therapy ,however clinical successes in 2009-2011 have bolstered new optimism in the promise of gene therapy. These include successful treatment of patients with the retinal disease Leber congenital amaurosis X¿linked SCID, ADA-SCID, adrenoleukodystrophy, and Parkinson's diseaseVDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 84 pp. Englisch. N° de réf. du vendeur 9786204985480
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Gene Therapy: Gene Delivery Systems And Treatment Of Rare Diseases | Dileep Kuamr (u. a.) | Taschenbuch | Englisch | 2022 | LAP LAMBERT Academic Publishing | EAN 9786204985480 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 123148429
Quantité disponible : 5 disponible(s)